VPCIR Biosciences is an innovative brand that has revolutionized Tuberculosis testing with its groundbreaking VPCIR™ Technology. With their patented technology, they have made it possible to detect living pathogens in saliva, offering an easy, precise, and cost-effective solution for Tuberculosis testing. Unlike traditional testing methods, their non-invasive Tuberculosis test stick eliminates the need for sputum samples and specialized equipment.

It provides results quickly, saving buyers approximately 50% of the current price per test. Moreover, their lateral flow test is validated through clinical evaluation and field tests, and it is CE marked. VPCIR Biosciences is not stopping at Tuberculosis testing.

By 2030, they aim to introduce test sticks for other infectious diseases such as Malaria and Pox. Their technology, Rolling Circle Amplification, has the potential to detect a wide range of pathogens, from Pox diseases to HIV and Brucella. Committed to a healthier and more sustainable world, VPCIR Biosciences believes that access to quality healthcare is a fundamental human right.

They are dedicated to developing affordable and accessible solutions, and they actively contribute to global health goals set by the World Health Organization. With a team of experienced professionals and strong partnerships, VPCIR Biosciences is at the forefront of diagnostic innovation, providing safe and reliable lateral flow products of the highest quality